UNI MEDICAL (02666) subsidiary completes issuance of RMB 500 million corporate bonds.

UNI MEDICAL (02666) announces that in relation to the public issuance by China Universal Leasing Co., Ltd. (the Issuer), a wholly-owned subsidiary of the Company, of the 2026 third tranche corporate bonds (the Current Corporate Bonds) within the People's Republic of China (China), the Current Corporate Bonds were completed on September 23, 2026 in China. The final total principal amount of the Current Corporate Bonds is RMB 500 million, with a base term of five years commencing from September 23, 2026, and a fixed interest rate of 1.74%. At the end of the 3rd year and the end of the 4th year, the Issuer will have the redemption option and the option to adjust the coupon rate, while investors will have the put option. The issue price is RMB 100 per bond, equivalent to 100% of the face value of the Current Corporate Bonds.